NCT06741241 Effectiveness of an eHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
| NCT ID | NCT06741241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida A&M University |
| Condition | Cervical Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 170 participants |
| Start Date | 2026-09-03 |
| Primary Completion | 2029-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 170 participants in total. It began in 2026-09-03 with a primary completion date of 2029-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test the effectiveness of an eHealth promotora (lay health advisor) outreach strategy to increase cervical cancer screening in Hispanic women. The investigators will recruit 160 Hispanic women ages 21-65 who are not up to date with cervical cancer screening or have never been screened, with the goal to evaluate screening knowledge, behavior, and intervention effects on cervical cancer screening outcomes. The study will utilize a two-arm, cluster randomized trial design, and participants will be randomly assigned to the cervical cancer education intervention or a nutrition education control group. The cervical cancer education arm will utilize a promotora to deliver an educational session virtually to encourage cervical cancer screening and receive a resource list for screening sites. The control group will participate in an educational session virtually about the importance of healthy nutrition. The primary study outcome is receipt of cervical cancer screening measured six months following receiving the intervention. The secondary outcomes will include cervical cancer screening knowledge and self-efficacy (confidence to receive cervical cancer screening). The research objective is to test the eHealth promotora intervention effectiveness for promoting cervical cancer screening in an under-screened Hispanic population.
Eligibility Criteria
Inclusion Criteria: 1. between the age of 21 and 65 years 2. identify as Hispanic 3. not up-to-date with cervical cancer screening \[never screened or last Pap test ≥ 3 years - based on U.S. Preventive Services Task Force guidelines\] 4. have no history of cervical cancer 5. have not had a hysterectomy. Exclusion Criteria: 1. under the age of 21 or over the age of 65 years 2. do not identify as Hispanic 3. up-to-date with cervical cancer screening \[last Pap test \< 3 years - based on U.S. Preventive Services Task Force guidelines\] 4. history of cervical cancer 5. have had a hysterectomy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06741241 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 65 Years, studying Cervical Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741241 currently recruiting?
Yes, NCT06741241 is actively recruiting participants. Contact the research team at tanise.jackson@famu.edu for enrollment information.
Where is the NCT06741241 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT06741241 clinical trial?
NCT06741241 is sponsored by Florida A&M University. The trial plans to enroll 170 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.